Biodegradable cationic polyesters for therapeutic delivery
Biodegradable cationic polyesters, with hydrolysable ester bonds and cationic side groups, offer enhanced degradation rates and potential for therapeutic delivery applications. Scalable production methods are being optimized for industrial deployment.
Overview
Biodegradable cationic polyesters are an innovative class of polymers designed for therapeutic delivery applications. These polymers incorporate hydrolysable ester bonds and cationic side groups, resulting in enhanced degradation rates under aqueous conditions. This feature makes them suitable for applications where controlled degradation and biocompatibility are crucial. The ability to adjust the synthetic design allows for cost-effective production, catering to diverse application needs.
Technical specifications
Key features:
- Composed of hydrolysable ester bonds and cationic side groups
- High degradation rates in aqueous environments
- Tailorable synthetic designs for cost-effective production
- Suitable for therapeutic delivery applications
Production capabilities:
- Gram-scale samples for initial assessments
- Optimization for kilogram-scale production using a 5-liter reactor
- Technical support for larger-scale industrial production
Technology readiness level
The technology is currently at TRL 5, indicating that the cationic polyesters have been validated in a lab environment. Ongoing efforts include further scale-up and optimization studies to transition to larger-scale production, with technical readiness for kilogram-scale production expected within 6 to 12 months.
About University at Buffalo, State University of New York
University at Buffalo is a comprehensive public research university and a leading campus in the State University of New York system. Industry engagement is anchored by co-located labs on a downtown medical campus, a research and technology park with incubators, shared core facilities, and co-op talent pipelines. Partnerships with regional hospitals enable clinical studies and translation, while proximity to the U.S.–Canada border and the binational Great Lakes corridor facilitates cross‑border collaboration. Research is supported by competitive federal funding from NIH, NSF, DOE, and DoD, alongside New York State innovation programs. A dedicated technology transfer office provides IP management, licensing, and startup support.
delivered to your inbox.